Are the two main competitors for SRPT still PTC Therapeutics and Prosensa?
How do you see the "race" going?
Am I wrong in thinking that on some level investments in SRPT and PTCT could be complimentary?
I mean, they are seeking to address different causes of the disease and in that regard are not in direct
competition? If so, was thinking of taking a small position in PTCT and was interested in opinions of that.